All subjects
Sustainable Aviation Fuel

Mitsubishi and Yield10 to explore feedstock partnership

Mitsubishi and Yield10 to explore feedstock partnership
Camelina (Camelina sativa) is an annual oilseed that grows to about 50 cm high (photo courtesy By Ranch).

In the United States (US), Yield10 Bioscience, Inc. (Yield10), an agricultural bioscience company, has announced that it has signed a Memorandum of Understanding (MoU) with Mitsubishi Corporation (Mitsubishi) to evaluate the establishment of a partnership to supply, offtake, and market Camelina as a low-carbon feedstock oil for biofuels.

An error occurred

You are logged in as subsbriber at Bioenergy International, but something is wrong.

On your profile you can see what subscriptions you have access to and more information.

Is some of the information wrong – please contact our customer service.

Please reload the page

We could not ascertain if you are logged in or not. Please reload this page.
Bioenergy International premium

Do you want to read the whole article?

Only logged in payed subscribers can read all contents on
As an subscriber you get:
  • Six editions per year
  • Full access to all digital content
  • The E-magazine Bioenergy international
  • And more ...

Mitsubishi recently announced its aim to mass produce sustainable aviation fuel (SAF) to decarbonize commercial aviation.

Under the MoU, the companies plan to jointly undertake a feasibility study for the supply and offtake of Camelina oil from Camelina grain grown under contract using Yield10’s proprietary Camelina seed genetics to supply oil for the SAF market.

In addition, the companies also plan to jointly study the development and future offtake and marketing of PHA bioplastic produced in Camelina by Yield10 as an added value co-product with oil for biofuels.

The MoU is non-binding and expires at the end of 2023.

Yield10 and Mitsubishi are aligned on the sustainability benefits that the Camelina crop could bring to the transportation fuels market. Over the next several months, we look forward to working with the Mitsubishi team to develop a framework for collaboration to jointly develop and build our Camelina business in the US and other important geographies said Dr Oliver Peoples, President, and CEO of Yield10 Bioscience.

Most read on Bioenergy International

Get the latest news about Bioenergy

Subscribe for free to our newsletter
Sending request
I accept that Bioenergy International stores and handles my information.
Read more about our integritypolicy here